Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 51 entries
View as:

Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal

Phase: N/A Priority: Normal
NCT ID: NCT03746327 Org: User:
Start: 02/13/20 End: 03/10/24 Due: 03/10/25

Open-label Study in Patients With Metastatic NSLC Treated With Cisplatin, Gemcitabine and Bevacizumab

Phase: N/A Priority: Normal
NCT ID: NCT02316327 Org: User:
Start: 07/31/13 End: 10/31/16 Due: 10/31/17

Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)

Phase: N/A Priority: Normal
NCT ID: NCT06896617 Org: User:
Start: 02/01/25 End: 12/20/26 Due: 12/20/27

Validation of the Efficacy of the Tool GIMIAS® for the Assessment of Left Atrial Fibrosis in a Group of Healthy Volunteers (RESTORE-HV)

Phase: N/A Priority: Normal
NCT ID: NCT02274246 Org: User:
Start: 11/30/14 End: 03/31/15 Due: 03/31/16

Safety, Tolerability, and Efficacy of a Dose Reduction Strategy Based on Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-infected Adults

Phase: N/A Priority: Normal
NCT ID: NCT05602506 Org: User:
Start: 11/15/22 End: 06/05/24 Due: 06/05/25

Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION)

Phase: N/A Priority: Normal
NCT ID: NCT04316182 Org: User:
Start: 07/31/20 End: 02/22/23 Due: 02/22/24

Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT04414735 Org: User:
Start: 08/17/22 End: 12/31/25 Due: 12/31/26

EFFECTS OF ABATACEPT on the Progression to Rheumatoid Arthritis(PALABA Study)

Phase: N/A Priority: Normal
NCT ID: NCT03669367 Org: User:
Start: 06/03/19 End: 09/30/24 Due: 09/30/25

Understanding the Transition from Normal Melanocytes to Nevus to Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06605417 Org: User:
Start: 01/01/24 End: 11/30/26 Due: 11/30/27

Dialectical Behavioral Therapy in Adolescents With Suicidal Behaviors

Phase: N/A Priority: Normal
NCT ID: NCT02406625 Org: User:
Start: 11/30/14 End: 02/28/17 Due: 02/28/18

Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02243982 Org: User:
Start: 03/31/10 End: 12/31/12 Due: 12/31/13

Albumin for Management of Hypervolemic Hyponatremia (AlbuCAT)

Phase: N/A Priority: Normal
NCT ID: NCT03941405 Org: User:
Start: 02/01/20 End: 01/30/25 Due: 01/30/26

Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia.

Phase: N/A Priority: Normal
NCT ID: NCT05914077 Org: User:
Start: 09/13/23 End: 01/31/25 Due: 01/31/26

Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT03360682 Org: User:
Start: 04/12/18 End: 01/31/21 Due: 01/31/22

Randomized Trial With Dendritic Cells in Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01413295 Org: User:
Start: 08/31/11 End: 09/30/14 Due: 09/30/15

Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery Stage

Phase: N/A Priority: Normal
NCT ID: NCT06183788 Org: User:
Start: 01/16/23 End: 11/30/25 Due: 11/30/26

Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

Phase: N/A Priority: Normal
NCT ID: NCT05398679 Org: User:
Start: 08/17/22 End: 12/30/27 Due: 12/30/28

Intralesional Tolerogenic Dendritic Cells in Crohn's Disease Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02622763 Org: User:
Start: 11/30/15 End: 05/05/19 Due: 05/05/20

To Optimize Antenatal Management of Women With Pre Term Labor Using Amniocentesis

Phase: N/A Priority: Normal
NCT ID: NCT04831086 Org: User:
Start: 05/05/21 End: 12/30/24 Due: 12/30/25

Precision Medicine for L/GCMN and Melanoma 1

Phase: N/A Priority: Normal
NCT ID: NCT06608420 Org: User:
Start: 03/01/24 End: 11/30/26 Due: 11/30/27

Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT06852625 Org: User:
Start: 05/31/25 End: 03/31/28 Due: 03/31/29

Precision Medicine for L/GCMN and Melanoma 2

Phase: N/A Priority: Normal
NCT ID: NCT06605443 Org: User:
Start: 01/01/25 End: 12/01/26 Due: 12/01/27

Laryngeal Mask Use in Knee-chest Position in Lumbar Surgery in Neurosurgical Patients

Phase: N/A Priority: Normal
NCT ID: NCT02162368 Org: User:
Start: 01/31/08 End: 11/30/15 Due: 11/30/16

Validation of a microRNA-based Fecal (miRFec) Test for Colorectal Cancer Screening, Surveillance and Diagnosis

Phase: N/A Priority: Normal
NCT ID: NCT05346757 Org: User:
Start: 03/23/22 End: 01/31/27 Due: 01/31/28

Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

Phase: N/A Priority: Normal
NCT ID: NCT07018947 Org: User:
Start: 11/30/25 End: 11/30/30 Due: 11/30/31